Tetra Biopharma Phase III Produkt kurz vor Markteinführung (Seite 24)

Begriffe und/oder Benutzer


Kann mir mal jemand sagen, wieso die Aktie heute so abstürzt und immer mehr an Boden verliert?
Testphase 3 ist doch bald abgeschlossen und dann geht's nur noch bergauf....
Tetra Bio-Pharma | 0,200 C$
Tetra Bio-Pharma Signs Definitive Commercialization Agreement for CAUMZ™ in Mexico With Alternavida S.A.
Alternavida to launch and fund 2 clinical sites in Mexico as part of the clinical research collaboration in the commercialization agreement

Collaboration potentially allows Tetra to accelerate Phase 3 (Serenity) and Phase 2 (fibromyalgia) enrollments with projected cost savings of CAD$10 million

OTTAWA, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it has signed a definitive co-development and commercialization agreement (“Agreement”) with Alternavida S.A. de C.V. (“Alternavida”) for the clinical development, marketing and distribution of CAUMZTM (PPP011) in Mexico.

“As the opioid crisis spreads from North America to other countries like Mexico1, controlling the global opioid epidemic has become one of the health challenges of our decade. Alternavida’s vision to open clinical sites for trials with CAUMZTM, and seeking drug approval, testifies to its leadership as a pharmaceutical company dedicated to the health and wellness of Mexicans," commented Dr. Guy Chamberland, CEO and Chief Regulatory Officer of Tetra Bio-Pharma. Chamberland added, "We have had discussions with numerous potential partners, but Alternavida had a clear interest in joining us in developing and bringing CAUMZTM to market. Our relationship will grow over the years, and we look forward to working with this forward-thinking company as we join forces in Mexico."
Tetra Bio-Pharma | 0,460 C$

Jetzt ist vielleicht noch der Punkt, wo man günstig reinkommt, demnächst sehen wir hier andere Kurse:eek:
Tetra Bio-Pharma | 0,320 €
Antwort auf Beitrag Nr.: 62.123.213 von HeinzBork am 10.12.19 15:29:17Die Aktie hat in D noch keine Aufmerksamkeit erlangt. Ich halte das Papier schon länger und hoffe, dass nun endlich der Knoten mal platzt.
Tetra Bio-Pharma | 0,351 €
Der Grund für den Anstieg
Tetra Bio Pharma (TSXV: TBP) is currently seeing upward price momentum on the discovery that one of its products appears to have been approved by Health Canada. The online Health Canada products database has listed one of the company’s products as “approved,” with the status change date being listed as January 15, 2020.

The product that has been approved for over the counter, or OTC sales is known as Terpacan Back & Muscle Pain, and is one of the first products to be approved by Health Canada that contains known cannabinoids. The product is a topical targeted towards pain relief, and has been assigned the DIN, or drug identification number, of 02495708.

Das dürfte erst der Anfang sein, schliesslich warten wir noch auf das FDA Approval für CAUMZ, was TBP in ungeahnte Höhen katapultieren wird.

Aber für den Anfang sind die Weichen auf Durchfahrt geschaltet.📈
Tetra Bio-Pharma | 0,386 €

Beitrag zu dieser Diskussion schreiben